<?xml version="1.0" encoding="UTF-8"?><ORDER xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://formex.publications.europa.eu/schema/formex-04.cj-20080212.xd"><BIB.ORDER><REF.CASE FILE="ECRT11990ENA.1000063701.case.xml"><NO.CASE>T-1/89</NO.CASE><NO.CASE>T-2/89</NO.CASE><NO.CASE>T-3/89</NO.CASE><NO.CASE>T-4/89</NO.CASE><NO.CASE>T-6/89</NO.CASE><NO.CASE>T-7/89</NO.CASE><NO.CASE>T-8/89</NO.CASE><NO.CASE>T-9/89</NO.CASE><NO.CASE>T-10/89</NO.CASE><NO.CASE>T-11/89</NO.CASE><NO.CASE>T-12/89</NO.CASE><NO.CASE>T-13/89</NO.CASE><NO.CASE>T-14/89</NO.CASE><NO.CASE>T-15/89</NO.CASE></REF.CASE><NO.CELEX>61989B0001</NO.CELEX><NO.SEQ>0027.0001</NO.SEQ><PAGE.FIRST>637</PAGE.FIRST><PAGE.SEQ>2</PAGE.SEQ><PAGE.LAST>648</PAGE.LAST><PAGE.TOTAL>12</PAGE.TOTAL><AUTHOR>T</AUTHOR></BIB.ORDER><CURR.TITLE><LEFT>ORDER OF <DATE ISO="19901115">15. 11. 1990</DATE>— JOINED CASES T-1/89 TO T-4/89 AND T-6/89 TO T-15/89</LEFT><RIGHT>RHÔNE-POULENC AND OTHERS v COMMISSION</RIGHT></CURR.TITLE><TITLE><TI><P><HT TYPE="UC">Order of the Court of First Instance</HT> (First Chamber)</P><P><DATE ISO="19901115">15 November 1990</DATE><NOTE NOTE.ID="E0001" NUMBERING="STAR"><P>Languages of the case:T-1/89 French, T-2/89 French,</P><P>T-3/89 French, T-4/89 German,</P><P>T-6/89 Italian, T-7/89 English,</P><P>T-8/89 Dutch, T-9/89 German,</P><P>T-10/89 German, T-11/89 English,</P><P>T-12/89 French, T-13/89 English,</P><P>T-14/89 Italian, T-15/89 German.</P></NOTE></P></TI></TITLE><ORDER.INIT><P>In Joined Cases T-1/89 to T-4/89 and T-6/89 to T-15/89,</P></ORDER.INIT><PARTIES><PLAINTIFS><P><HT TYPE="BOLD">Rhône Poulenc SA,</HT> whose registered office is at 25 quai Paul-Doumer, F-92408 Courbevoie (France), represented by R. Saint Esteben, avocat, with an address for service in Luxembourg at the Chambers of Messrs Loesch and Wolter, 8 rue Zithe,</P><?PAGE NO="II-638"?><P><HT TYPE="BOLD">Petrofina SA,</HT> having its registered office at 52, rue de l'Industrie, B-1040 Brussels, represented by G. Vandersanden and L. Defalque, avocats, with an address for service in Luxembourg at the Chambers of J. Biver, 8 rue Zithe,</P><P><HT TYPE="BOLD">Atochem SA,</HT> whose registered office is at 4 and 8 cours Michelet, La Défense 10, Puteaux, Hauts de Seine (France), represented by X. De Roux and C.-H. Léger, avocats, with an address for service in Luxembourg at the Chambers of Messrs Elvinger and Hoss, 15 côte d'Eich,</P><P><HT TYPE="BOLD">BASF Aktiengesellschaft,</HT> whose registered office is at 38 Carl-Bosch-Straße, D-6700 Ludwigshafen (Federal Republic of Germany), represented by F. Hermanns and U. F. Kleier, Rechtsanwälte, with an address for service in Luxembourg at the Chambers of J. Loesch, 8 rue Zithe,</P><P><HT TYPE="BOLD">Enichem Anie SpA,</HT> whose registered office is at 55 via Ruggero Settimo, Palermo (Italy), represented by G. Guarino, M. Siragusa and G. Arcidiacono, avocats, with an address for service in Luxembourg at the Chambers of Messrs Arendt and Harles, 4 avenue Marie-Thérèse,</P><P><HT TYPE="BOLD">SA Hercules Chemicals NV,</HT> whose registered office is at 1 Industriepark, B-3580 Beringen (Belgium), represented by M. Siragusa, avocat, of Messrs Geary, Gottlieb, Steen &amp; Hamilton, with an address for service in Luxembourg at the Chambers of Messrs Elvinger and Hoss, 15 côte d'Eich,</P><P><HT TYPE="BOLD">DSM NV,</HT> whose registered office is in Heerlen (Netherlands), represented by I. G. F. Cath, avocat, with an address for service in Luxembourg at the Chambers of L. H. Dupong, 14a rue des Bains,</P><P><HT TYPE="BOLD">Hüls Aktiengesellschaft,</HT> whose registered office is at 1 Paul-Baumann-Straße, D-4370 Marl (Federal Republic of Germany), represented by Messrs Deringer, Tessin, Herrmann und Sedemund, Rechtsanwälte, with an address for service in Luxembourg at the Chambers of Messrs Loesch and Wolter, 8 rue Zithe,</P><P><HT TYPE="BOLD">Hoechst Aktiengesellschaft,</HT> whose registered office is Postfach 800320, D-6230 Frankfurt am Main (Federal Republic of Germany), represented by H. Hellmann, Rechtsanwalt, with an address for service in Luxembourg at the Chambers of Messrs Loesch and Wolter, 8 rue Zithe,</P><?PAGE NO="II-639"?><P><HT TYPE="BOLD">Shell International Chemical Company Ltd,</HT> whose registered office is London SE 1 7PG (United Kingdom), represented by J. F. Lever QC and K. B. Parker, barrister, instructed by J. W. Osborne of Messrs Clifford Chance, solicitors, with an address for service in Luxembourg at the Chambers of Messrs Elvinger and Hoss, 15 côte d'Eich,</P><P><HT TYPE="BOLD">SA Solvay &amp; Compagnie,</HT> whose registered office is 33 rue du Prince-Albert, B-1050 Brussels, represented by L. Simont, avocat, with an address for service in Luxembourg at the Chambers of Messrs Loesch and Wolter, 8 rue Zithe,</P><P><HT TYPE="BOLD">Imperial Chemical Industries, pic,</HT> whose registered office is at Millbank, London SW 1 (United Kingdom), represented by D. Vaughan QC and D. Andersen, barrister, and by V. O. White and R. J. Coles, solicitors, with an address for service in Luxembourg at the Chambers of L. H. Dupong, 14a rue des Bains,</P><P><HT TYPE="BOLD">Montedipe SpA,</HT> whose registered office is in Milan (Italy), represented by G. Celona and by P. M. Ferrari, F. Capelli and G. Aghina, avvocati, with an address for service in Luxembourg at the Chambers of G. Margue, 20 rue Phillipe-II,</P><P><HT TYPE="BOLD">Chemie Linz AG,</HT> whose registered office is in Linz (Austia), represented by Mr Lieberknecht of Messrs Bruckaus, Kreifels, Winkhaus und Lieberknecht, with an address for service in Luxembourg at the Chambers of A. Bonn, 20 côte d'Eich,</P><PARTY.STATUS>applicants,</PARTY.STATUS></PLAINTIFS><AGAINST>v</AGAINST><DEFENDANTS><P><HT TYPE="BOLD">Commission of the European Communities,</HT> represented by its Legal Advisers, A. Mc Clellan and G. Marenco, B. Jansen and K. Banks, members of its Legal Department, assisted by Messrs Coutrelis et associés, avocats, and by T. R. Ottervanger, Rechtsanwalt, with an address for service in Luxembourg at the office of Guido Berardis, a member of the Commission's Legal Department, Wagner Centre, Kirchberg,</P><PARTY.STATUS>defendant,</PARTY.STATUS></DEFENDANTS></PARTIES><SUBJECT><P>APPLICATION for a declaration that the Commission decision of <DATE ISO="19860423">23 April 1986</DATE> relating to a proceeding under Article 85 of the EEC Treaty (IV/31.149, Polypropylene) is void,</P></SUBJECT><?PAGE NO="II-640"?><PREAMBLE.GEN><PREAMBLE.INIT><P>THE COURT OF FIRST INSTANCE (First Chamber)</P><P>composed of: J. L. Cruz Vilaça, President, R. Schintgen, D. A. O. Edward, H. Kirschner and K. Lenaerts, Judges,</P><P>Advocate General: B. Vesterdorf</P><P>Registrar: H. Jung</P></PREAMBLE.INIT><PREAMBLE.FINAL><P>makes the following</P></PREAMBLE.FINAL></PREAMBLE.GEN><CONTENTS.ORDER><GR.SEQ LEVEL="1"><TITLE><TI><P>Order</P></TI></TITLE><NP><NO.P>1</NO.P><TXT>By letters dated <DATE ISO="19900709">9 July 1990</DATE> sent by the Registrar, the Court requested the parties to submit any observations they might have on the joinder of Cases T-1 to T-4/89 and T-6 to T-15/89 for the purposes of the oral procedure and, in the event of joinder, any requests they might have for confidential treatment of their pleadings, or of annexes thereto, or of both, together with a <QUOT.START ID="QS0001" REF.END="QE0001" CODE="2018"/>brief statement of reasons<QUOT.END ID="QE0001" REF.START="QS0001" CODE="2019"/>.</TXT></NP><NP><NO.P>2</NO.P><TXT>By a letter received at the Court on <DATE ISO="19900718">18 July 1990</DATE>, the applicant in Case T-2/89 lodged a request for the confidential treatment of certain material contained in its application and in its reply and of all the annexes to its application and one annex to its reply. However, it did not provide the brief statement of reasons requested by the Court.</TXT></NP><NP><NO.P>3</NO.P><TXT>By a letter received at the Court on <DATE ISO="19900725">25 July 1990</DATE>, the applicant in Case T-3/89 lodged a request for the confidential treatment of certain material contained in its application and in its reply and of certain material contained in an annex to its application and one annex to its reply. However, it did not provide the brief statement of reasons requested by the Court.</TXT></NP><?PAGE NO="II-641"?><NP><NO.P>4</NO.P><TXT>By letters received at the Court on 10 and <DATE ISO="19900723">23 July 1990</DATE>, the applicant in Case T-4/89 lodged a request for the confidential treatment of an annex to its application. However, it did not provide the brief statement of reasons requested by the Court.</TXT></NP><NP><NO.P>5</NO.P><TXT>By a letter received at the Court on <DATE ISO="19900712">12 July 1990</DATE>, the applicant in Case T-9/89 lodged a request for the confidential treatment of certain material contained in its application and of certain annexes thereto. It merely stated that this material constituted <QUOT.START ID="QS0002" REF.END="QE0002" CODE="2018"/>secrets d'affaires<QUOT.END ID="QE0002" REF.START="QS0002" CODE="2019"/> and did not provide the brief statement of reasons requested by the Court.</TXT></NP><NP><NO.P>6</NO.P><TXT>By letter received at the Court on <DATE ISO="19900724">24 July 1990</DATE>, the applicant in Case T-11/89 lodged a request for the confidential treatment of certain material contained in its reply and of all the annexes to its pleadings. It stated that:</TXT><P><QUOT.S LEVEL="1"><P><QUOT.START ID="QS0003" REF.END="QE0003" CODE="2018"/>As to the annexes to the pleadings which have been lodged with the Registry, our clients would prefer that these not be made available for consultation by lawyers representing the other applicants. However, if any lawyer representing another applicant wishes to examine any of the annexes in our case they are at liberty to contact me direct, whereupon I will review with SICC whether there is any difficulty in that lawyer examining any class of documents or any particular document. As a general principle I believe that the copies of the pleadings may be made available to the lawyers representing the other applicants, including in-house lawyers, but not to commercial executives of their clients.<QUOT.END ID="QE0003" REF.START="QS0003" CODE="2019"/></P></QUOT.S></P></NP><NP><NO.P>7</NO.P><TXT>By a letter received at the Court on <DATE ISO="19900724">24 July 1990</DATE>, the applicant in Case T-12/89 lodged a request for the confidential treatment of certain material contained in one page of its application and in two annexes to its application and in one annex to its reply. It stated that:</TXT><P><QUOT.S LEVEL="1"><P><QUOT.START ID="QS0004" REF.END="QE0004" CODE="2018"/>The application lodged by Solvay et Cie SA, some of the annexes thereto and some of the annexes to the reply contain material enabling the production costs of the products in question to be determined and are considered to be confidential by<?PAGE NO="II-642"?> my client. Since this material may not be disclosed to the other parties, I enclose herewith a non-confidential version of the following documents ... <QUOT.END ID="QE0004" REF.START="QS0004" CODE="2019"/>.</P></QUOT.S></P></NP><NP><NO.P>8</NO.P><TXT>By a letter received at the Court on <DATE ISO="19900725">25 July 1990</DATE>, the applicant in Case T-13/89 indicated that:</TXT><P><QUOT.S LEVEL="1"><P><QUOT.START ID="QS0005" REF.END="QE0005" CODE="2018"/>The full text of the ICI defences which form Annexes 3(a), (b) and (c) to ICI's application should not be communicated to the parties in other cases ... Annex 9 to ICI's application and the Coopers and Lybrand Audit which forms Exhibit 4 to ICI's application should not be disclosed at all to other parties. Finally, the figures at Section 16. D.2. of ICI's application should also not be communicated to other parties.<QUOT.END ID="QE0005" REF.START="QS0005" CODE="2019"/></P></QUOT.S></P><P>It pointed out that <QUOT.START ID="QS0006" REF.END="QE0006" CODE="2018"/>the position with regard to the confidentiality of ICI's pleadings is set out in Section 1.5 of ICI's application<QUOT.END ID="QE0006" REF.START="QS0006" CODE="2019"/>, in which it simply states that those documents <QUOT.START ID="QS0007" REF.END="QE0007" CODE="2018"/>contain much confidential material<QUOT.END ID="QE0007" REF.START="QS0007" CODE="2019"/> and requests that they <QUOT.START ID="QS0008" REF.END="QE0008" CODE="2018"/>be not disclosed at all<QUOT.END ID="QE0008" REF.START="QS0008" CODE="2019"/>.</P></NP><NP><NO.P>9</NO.P><TXT>The Commission has not raised any objections to the requests for confidential treatment lodged by the various applicants.</TXT></NP><NP><NO.P>10</NO.P><TXT>After establishing that there was no objection to the joinder of the cases, the Court, by order of <DATE ISO="19900925">25 September 1990</DATE>, joined Cases T-1 to T-4/89 and T-6 to T-15/89 for the purposes of the oral procedure owing to the their related nature, in accordance with Article 43 of the Rules of Procedure of the Court of Justice, applicable <HT TYPE="ITALIC">mutatis mutandis</HT> by virtue of Article 11(3) of the Council Decision of <DATE ISO="19881024">24 October 1988</DATE> establishing a Court of First Instance of the European Communities.</TXT></NP><NP><NO.P>11</NO.P><TXT>After finding that in their abovementioned letters, the applicants had not provided the statement of reasons requested by the Court or had not done so sufficiently, the Court requested the applicants in Cases T-2/89, T-9/89, T-l 1/89, T-12/89 and T-13/89, first, <QUOT.START ID="QS0009" REF.END="QE0009" CODE="2018"/>to indicate the specific information ... for which [they request]<?PAGE NO="II-643"?> confidential treatment<QUOT.END ID="QE0009" REF.START="QS0009" CODE="2019"/> and, secondly, <QUOT.START ID="QS0010" REF.END="QE0010" CODE="2018"/>to state clearly in respect of each item of information (or type of information) ... the reasons on which [their] request for confidential treatment is based, regard being had to the age of the information in question<QUOT.END ID="QE0010" REF.START="QS0010" CODE="2019"/>, and the applicants in Cases T-3/89 and T-4/89 <QUOT.START ID="QS0011" REF.END="QE0011" CODE="2018"/>to give a clear statement of the reasons for which [they are] requesting confidential treatment in respect of each item of information (or type of information) ... regard being had to the age of the information in question<QUOT.END ID="QE0011" REF.START="QS0011" CODE="2019"/>.</TXT></NP><NP><NO.P>12</NO.P><TXT>By a letter received at the Court on <DATE ISO="19901109">9 November 1990</DATE>, the applicant in Case T-2/89 indicated that:</TXT><P><QUOT.S LEVEL="1"><P><QUOT.START ID="QS0012" REF.END="QE0012" CODE="2018"/>Petrofina considers that confidential treatment is a right which it cannot be refused. Would you therefore communicate to the other parties only the annexes as edited, omitted or left as such by Petrofina.<QUOT.END ID="QE0012" REF.START="QS0012" CODE="2019"/></P></QUOT.S></P></NP><NP><NO.P>13</NO.P><TXT>By a letter received at the Court on <DATE ISO="19901024">24 October 1990</DATE>, the applicant in Case T-4/89 withdrew its request for confidential treatment.</TXT></NP><NP><NO.P>14</NO.P><TXT>In a letter received at the Court on <DATE ISO="19901029">29 October 1990</DATE>, the applicant in Case T-12/89 stated that:</TXT><P><QUOT.S LEVEL="1"><P><QUOT.START ID="QS0013" REF.END="QE0013" CODE="2018"/>Having regard to the period in question in these cases, it is self-evident that the commercial information and statistics contained in the pleadings and annexes of the parties concerned go back several years. That being so, Solvay et Cie SA refers to my letter of <DATE ISO="19900723">23 July 1990</DATE> in which it was explained that the information obscured in the non-confidential version of the application and certain annexes to the reply was information which enabled the production costs of the products in question to be determined and that for that reason it had to be considered confidential. That statement of reasons should suffice.<QUOT.END ID="QE0013" REF.START="QS0013" CODE="2019"/></P></QUOT.S></P></NP><NP><NO.P>15</NO.P><TXT>By a letter received at the Court on <DATE ISO="19901016">16 October 1990</DATE>, the applicant in Case T-13/89 informed the Court that:</TXT><?PAGE NO="II-644"?><P><QUOT.S LEVEL="1"><P><QUOT.START ID="QS0014" REF.END="QE0014" CODE="2018"/>ICI has reviewed the material in question and waives its request for confidential treatment of p. 103 of the application and Annex 9 to the application on the basis that the information contained therein relating to ICI turnover is now so outdated as to be no longer commercially sensitive. However, ICI would ask the Court to accede to its request for confidential treatment of the full version of its various defences (whilst accepting disclosure of the edited versions) and also in respect of the Coopers and Lybrand Audit of ICI sales. All these documents contain information relating to individual customers of ICI and notwithstanding that the information is of a certain age it is none the less commercially sensitive.<QUOT.END ID="QE0014" REF.START="QS0014" CODE="2019"/></P></QUOT.S></P></NP><NP><NO.P>16</NO.P><TXT>In Cases T-3/89, T-9/89 and T-11/89, no replies to the Registrar's letter of <DATE ISO="19901010">10 October 1990</DATE> have been received.</TXT></NP><NP><NO.P>17</NO.P><TXT>In addition, by letters dated <DATE ISO="19900718">18 July 1990</DATE> sent by the Registrar, the Court requested the parties to reply in writing to certain questions. In their replies, some applicants submitted requests for confidential treatment concerning certain material in those replies or the annexes thereto.</TXT></NP><NP><NO.P>18</NO.P><TXT>By a letter received at the Court on <DATE ISO="19901016">16 October 1990</DATE>, the applicant in Case T-9/89 requested that</TXT><P><QUOT.S LEVEL="1"><P><QUOT.START ID="QS0015" REF.END="QE0015" CODE="2018"/>the information submitted in Hüls Annex 51 be treated confidentially since it concerns business secrets. The information contained therein, in so far as it was available, represents not only the total sales in the European Community but also the volume of sales in the various Member States, so that the other, parties concerned could draw conclusions from it concerning Hüls<QUOT.END ID="QE0015" REF.START="QS0015" CODE="2019"/> market share and conduct on that market. For those reasons, we request you not to send Annex 51 to the other applicants'.</P></QUOT.S></P></NP><NP><NO.P>19</NO.P><TXT>By a letter received at the Court on <DATE ISO="19901015">15 October 1990</DATE>, the applicant in Case T-11/89 pointed out, in its actual reply to Question 5, that the tables mentioned in its reply were marked <QUOT.START ID="QS0016" REF.END="QE0016" CODE="2018"/>Confidential — Business Secrets<QUOT.END ID="QE0016" REF.START="QS0016" CODE="2019"/>.</TXT></NP><?PAGE NO="II-645"?><NP><NO.P>20</NO.P><TXT>In a letter received at the Court on <DATE ISO="19901009">9 October 1990</DATE>, the applicant in Case T-13/89 marked a number of tables annexed to its reply to Question 5 as <QUOT.START ID="QS0017" REF.END="QE0017" CODE="2018"/>confidential<QUOT.END ID="QE0017" REF.START="QS0017" CODE="2019"/>. However, by a letter received at the Court of <DATE ISO="19901016">16 October 1990</DATE>, the applicant in Case T-13/89 informed the Court that:</TXT><P><QUOT.S LEVEL="1"><P><QUOT.START ID="QS0018" REF.END="QE0018" CODE="2018"/>With regard to the three pages of tables included in ICI's reply dated <DATE ISO="19901008">8 October 1990</DATE> to the questions put to it by the Court and which ICI has marked as confidential, ICI has reviewed the position in the light of the comments made in the Court's letter of <DATE ISO="19901010">10 October 1990</DATE>. It is content not to make any claim for confidential treatment in respect of such tables given the age of the information concerned.<QUOT.END ID="QE0018" REF.START="QS0018" CODE="2019"/></P></QUOT.S></P></NP><NP><NO.P>21</NO.P><TXT>It should be noted first of all that the requests for confidential treatment must be regarded as procedural issues within the meaning of Article 91(1) of the Rules of Procedure of the Court of Justice.</TXT></NP><NP><NO.P>22</NO.P><TXT>It should be noted, next, that when examining a request for confidential treatment where several cases have been joined the Court has to resolve a conflict between two opposing principles: on the one hand, the principle of the protection of business secrets and, on the other, the principle that all parties having a potential conflict of interest must be in a position to reply to any points adversely affecting them.</TXT></NP><NP><NO.P>23</NO.P><TXT>In the present case, the Court has examined the merits of the requests for confidential treatment in the light of, first, the attitude of some of the applicants which have not made requests for confidential treatment of information comparable to that referred to in the requests before the Court, secondly, the withdrawal by other applicants of their requests for confidential treatment of such information and, thirdly, the age of most of the information which other applicants still classify as <QUOT.START ID="QS0019" REF.END="QE0019" CODE="2018"/>business secrets<QUOT.END ID="QE0019" REF.START="QS0019" CODE="2019"/> without explaining how such old information can retain the character of <QUOT.START ID="QS0020" REF.END="QE0020" CODE="2018"/>a business secret<QUOT.END ID="QE0020" REF.START="QS0020" CODE="2019"/>.</TXT></NP><?PAGE NO="II-646"?><NP><NO.P>24</NO.P><TXT>Having regard to all the foregoing, it must be observed that, of all the requests for confidential treatment, only the following requests concern information which must still be regarded as concerning matters of business secrecy:</TXT><P><LIST TYPE="roman"><ITEM><NP><NO.P>(i)</NO.P><TXT>in Case T-2/89, the requests for confidential treatment concerning pp. 13 and 14 of the application and p. 39 of the reply, Annex 11 to the application, pp. 12 and 13 of Annex 14, pp. 6 to 8 of Annex 17, Annexes 19 and 20 to the application, as well as Appendix PET 5 of Annex 3 to the reply and Appendices PET 6/29 and PET 7/37 of Annex 3 to the reply but only so far as the information taken from the Coopers and Lybrand Audit is concerned;</TXT></NP></ITEM><ITEM><NP><NO.P>(ii)</NO.P><TXT>in Case T-3/89, the requests for confidential treatment concerning Appendices A6 and A7 of Annex 2 to the application;</TXT></NP></ITEM><ITEM><NP><NO.P>(iii)</NO.P><TXT>in Case T-9/89, the requests for confidential treatment concerning pp. 40, 62 and 97 of the application, p. 2 of Annex 26 to the application, and Annexes 30 to 35 to the application;</TXT></NP></ITEM><ITEM><NP><NO.P>(iv)</NO.P><TXT>in Case T-11/89, the requests for confidential treatment concerning pp. 114 and 115 of the reply; pp. 73 to 84, Appendices 1, 2, 4, 5 and number 13 of the <QUOT.START ID="QS0021" REF.END="QE0021" CODE="2018"/>contemporary documents<QUOT.END ID="QE0021" REF.START="QS0021" CODE="2019"/> in Annex 6 to the application as well as Exhibits C2, D1 and D2 and their <QUOT.START ID="QS0022" REF.END="QE0022" CODE="2018"/>typed copies<QUOT.END ID="QE0022" REF.START="QS0022" CODE="2019"/> in Appendix II of Annex 11 to the application;</TXT></NP></ITEM><ITEM><NP><NO.P>(v)</NO.P><TXT>in Case T-12/89, the requests for confidential treatment concerning p. 4 of the application, Annexes 6 and 7 to the application and Annex 2 to the reply;</TXT></NP></ITEM><ITEM><NP><NO.P>(vi)</NO.P><TXT>in Case T-13/89, the requests for confidential treatment concerning Annex 3(a) to the application, with the exception of Exhibits 6, first table, 18, 21 and 22; Annex 3(c) to the application, with the exception of the requests relating to Exhibit 5 and p. 17; as well as Exhibit 4 to the application, with the exception of the part entitled <QUOT.START ID="QS0023" REF.END="QE0023" CODE="2018"/>sales of polypropylene basic products to overlapping customers during the 21 months ended <DATE ISO="19830930">30 September 1983</DATE><QUOT.END ID="QE0023" REF.START="QS0023" CODE="2019"/>.</TXT></NP></ITEM></LIST></P></NP><?PAGE NO="II-647"?><NP><NO.P>25</NO.P><TXT>Those requests must, therefore, be granted. Since all the other requests for confidential treatment have been rejected, the information to which those requests relate will be made available to the parties which will be able to inspect it at the Registry of the Court.</TXT></NP></GR.SEQ><JURISDICTION><INTRO><P>On those grounds,</P><P>THE COURT OF FIRST INSTANCE (First Chamber)</P><P>hereby orders as follows:</P></INTRO><P>The following requests shall be granted:</P><LIST TYPE="roman"><ITEM><NP><NO.P>(i)</NO.P><TXT>in Case T-2/89, the requests for confidential treatment concerning pp. 13 and 14 of the application and p. 39 of the reply, Annex 11 to the application, pp. 12 and 13 of Annex 14, pp. 6 to 8 of Annex 17, Annexes 19 and 20 to the application, as well as Appendix PET 5 of Annex 3 to the reply and Appendices PET 6/29 and PET 7/37 of Annex 3 to the reply but only so far as the information taken from the Coopers and Lybrand Audit is concerned;</TXT></NP></ITEM><ITEM><NP><NO.P>(ii)</NO.P><TXT>in Case T-3/89, the requests for confidential treatment concerning Appendices A6 and A7 of Annex 2 to the application;</TXT></NP></ITEM><ITEM><NP><NO.P>(iii)</NO.P><TXT>in Case T-9/89, the requests for confidential treatment concerning pp. 40, 62 and 97 of the application, p. 2 of Annex 26 to the application, and Annexes 30 to 35 to the application;</TXT></NP></ITEM><ITEM><NP><NO.P>(iv)</NO.P><TXT>in Case T-11/89, the requests for confidential treatment concerning pp. 114 and 115 of the reply; pp. 73 to 84, Appendices 1, 2, 4, 5 and number 13 of the <QUOT.START ID="QS0024" REF.END="QE0024" CODE="2018"/>contemporary documents<QUOT.END ID="QE0024" REF.START="QS0024" CODE="2019"/> in Annex 6 to the application as well as Exhibits C2, D 1and D2 and their <QUOT.START ID="QS0025" REF.END="QE0025" CODE="2018"/>typed copies<QUOT.END ID="QE0025" REF.START="QS0025" CODE="2019"/> in Appendix II of Annex 11 to the application;</TXT></NP></ITEM><ITEM><NP><NO.P>(v)</NO.P><TXT>in Case T-12/89, the requests for confidenţial treatment concerning p. 4 of the application, Annexes 6 and 7 to the application and Annex 2 to the reply;</TXT></NP></ITEM><?PAGE NO="II-648"?><ITEM><NP><NO.P>(vi)</NO.P><TXT>in Case T-13/89, the requests for confidential treatment concerning Annex 3(a) to the application, with the exception of Exhibits 6, first table, 18, 21 and 22; Annex 3(c) to the application, with the exception of the requests relating to Exhibit 5 and p. 17; as well as Exhibit 4 to the application, with the exception of the part entitled <QUOT.START ID="QS0026" REF.END="QE0026" CODE="2018"/>sales of polypropylene basic products to overlapping customers during the 21 months ended <DATE ISO="19830930">30 September 1983</DATE><QUOT.END ID="QE0026" REF.START="QS0026" CODE="2019"/>.</TXT></NP></ITEM></LIST></JURISDICTION></CONTENTS.ORDER><SIGNATURE.CASE><P>Luxembourg, <DATE ISO="19901115">15 November 1990</DATE>.</P><SIGNATORY><P>H.Jung</P><P>Registrar</P></SIGNATORY><SIGNATORY><P>J. L. Cruz Vilaça</P><P>President</P></SIGNATORY></SIGNATURE.CASE></ORDER>